Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.

Chaudru V, Lo MT, Lesueur F, Marian C, Mohamdi H, Laud K, Barrois M, Chompret A, Avril MF, Demenais F, Bressac-de Paillerets B.

Fam Cancer. 2009;8(4):371-7. doi: 10.1007/s10689-009-9249-5. Epub 2009 May 31.

PMID:
19484507
2.

Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.

Chaudru V, Laud K, Avril MF, Minière A, Chompret A, Bressac-de Paillerets B, Demenais F.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2384-90.

3.

Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.

Goldstein AM, Landi MT, Tsang S, Fraser MC, Munroe DJ, Tucker MA.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2208-12.

4.

Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.

Mössner R, Anders N, König IR, Krüger U, Schmidt D, Berking C, Ziegler A, Brockmöller J, Kaiser R, Volkenandt M, Westphal GA, Reich K.

Arch Dermatol Res. 2007 Jan;298(8):371-9. Epub 2006 Oct 28.

PMID:
17072629
5.

Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism.

Ibarrola-Villava M, Martin-Gonzalez M, Lazaro P, Pizarro A, Lluch A, Ribas G.

Br J Dermatol. 2012 Jun;166(6):1176-83. doi: 10.1111/j.1365-2133.2012.10831.x. Epub 2012 Apr 4.

PMID:
22251241
6.

Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.

Chaudru V, Chompret A, Bressac-de Paillerets B, Spatz A, Avril MF, Demenais F.

J Natl Cancer Inst. 2004 May 19;96(10):785-95.

PMID:
15150307
7.

MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.

Fargnoli MC, Gandini S, Peris K, Maisonneuve P, Raimondi S.

Eur J Cancer. 2010 May;46(8):1413-20. doi: 10.1016/j.ejca.2010.01.027. Epub 2010 Feb 26. Review.

PMID:
20189796
8.

Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.

Cuéllar F, Puig S, Kolm I, Puig-Butille J, Zaballos P, Martí-Laborda R, Badenas C, Malvehy J.

Br J Dermatol. 2009 Jan;160(1):48-53. doi: 10.1111/j.1365-2133.2008.08826.x. Epub 2008 Sep 15.

PMID:
18795926
9.

Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.

Fargnoli MC, Altobelli E, Keller G, Chimenti S, Höfler H, Peris K.

Melanoma Res. 2006 Apr;16(2):175-82.

PMID:
16567973
10.

MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.

Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM.

J Natl Cancer Inst. 2005 Jul 6;97(13):998-1007. Erratum in: J Natl Cancer Inst. 2005 Sep 21;97(18):1385.

PMID:
15998953
11.

Ocular melanoma is not associated with CDKN2A or MC1R variants--a population-based study.

Vajdic C, Kricker A, Duffy DL, Aitken JF, Stark M, ter Huurne JA, Martin NG, Armstrong BK, Hayward NK.

Melanoma Res. 2003 Aug;13(4):409-13.

PMID:
12883368
12.

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.

Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, Hayward NK.

Am J Hum Genet. 2001 Oct;69(4):765-73. Epub 2001 Aug 8.

13.

MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters.

Höiom V, Tuominen R, Käller M, Lindén D, Ahmadian A, Månsson-Brahme E, Egyhazi S, Sjöberg K, Lundeberg J, Hansson J.

Pigment Cell Melanoma Res. 2009 Apr;22(2):196-204. doi: 10.1111/j.1755-148X.2008.00526.x. Epub 2008 Dec 9.

PMID:
19077144
14.

Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.

Ibarrola-Villava M, Fernandez LP, Pita G, Bravo J, Floristan U, Sendagorta E, Feito M, Avilés JA, Martin-Gonzalez M, Lázaro P, Benítez J, Ribas G.

Exp Dermatol. 2010 Sep;19(9):836-44. doi: 10.1111/j.1600-0625.2010.01115.x. Epub 2010 Jul 14.

PMID:
20629734
15.

Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.

Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D.

Arch Dermatol. 2007 Apr;143(4):495-9.

PMID:
17438182
16.

Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India.

Pandey SN, Jain M, Nigam P, Choudhuri G, Mittal B.

Biomarkers. 2006 May-Jun;11(3):250-61.

PMID:
16760134
17.

Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.

Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D.

Mutat Res. 2008 Feb 1;638(1-2):184-94. Epub 2007 Oct 16.

PMID:
18035380
18.

MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.

Ghiorzo P, Bonelli L, Pastorino L, Bruno W, Barile M, Andreotti V, Nasti S, Battistuzzi L, Grosso M, Bianchi-Scarrà G, Queirolo P.

Exp Dermatol. 2012 Sep;21(9):718-20. doi: 10.1111/j.1600-0625.2012.01549.x.

PMID:
22804906
19.

Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.

Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, Madhavan J, Ankathil R.

J Exp Ther Oncol. 2008;7(1):73-85.

PMID:
18472644
20.

Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.

Demenais F, Mohamdi H, Chaudru V, Goldstein AM, Newton Bishop JA, Bishop DT, Kanetsky PA, Hayward NK, Gillanders E, Elder DE, Avril MF, Azizi E, van Belle P, Bergman W, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Carrera C, Hansson J, Harland M, Hogg D, Höiom V, Holland EA, Ingvar C, Landi MT, Lang JM, Mackie RM, Mann GJ, Ming ME, Njauw CJ, Olsson H, Palmer J, Pastorino L, Puig S, Randerson-Moor J, Stark M, Tsao H, Tucker MA, van der Velden P, Yang XR, Gruis N; Melanoma Genetics Consortium..

J Natl Cancer Inst. 2010 Oct 20;102(20):1568-83. doi: 10.1093/jnci/djq363. Epub 2010 Sep 28.

Supplemental Content

Support Center